Cargando…

A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection

BACKGROUND: Esophageal stenosis following endoscopic submucosal dissection (ESD) is a serious adverse event that makes subsequent management more difficult. METHODS: This parallel, randomized, controlled, open-label study was designed to examine whether local steroid injection is an effective prophy...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Hiroaki, Arimura, Yoshiaki, Okahara, Satoshi, Kodaira, Junichi, Hokari, Kaku, Tsukagoshi, Hiroyuki, Shinomura, Yasuhisa, Hosokawa, Masao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308850/
https://www.ncbi.nlm.nih.gov/pubmed/25609176
http://dx.doi.org/10.1186/s12876-014-0226-6
_version_ 1782354596632461312
author Takahashi, Hiroaki
Arimura, Yoshiaki
Okahara, Satoshi
Kodaira, Junichi
Hokari, Kaku
Tsukagoshi, Hiroyuki
Shinomura, Yasuhisa
Hosokawa, Masao
author_facet Takahashi, Hiroaki
Arimura, Yoshiaki
Okahara, Satoshi
Kodaira, Junichi
Hokari, Kaku
Tsukagoshi, Hiroyuki
Shinomura, Yasuhisa
Hosokawa, Masao
author_sort Takahashi, Hiroaki
collection PubMed
description BACKGROUND: Esophageal stenosis following endoscopic submucosal dissection (ESD) is a serious adverse event that makes subsequent management more difficult. METHODS: This parallel, randomized, controlled, open-label study was designed to examine whether local steroid injection is an effective prophylactic treatment for esophageal stenoses following extensive ESD. This single center trial was conducted at the Keiyukai Hospital, a tertiary care center for gastrointestinal disease in Japan [University Hospital Medical Network Clinical Trial Registry (UMIN-CTR) on 15 September 2011 (UMIN000006327)]. Thirty-two patients with mucosal defects involving ≥75% of the esophageal circumference were randomized to receive a single dose of triamcinolone acetonide injections (n = 16) or be treated conventionally (n = 16). The primary outcome was the frequency of stricture requiring endoscopic dilatation; the surrogate primary endpoint was the number of dilatation sessions needed. Secondary outcomes included adverse event rates, the minimum diameter of the stenotic area and the duration of the course of dilatation treatments. RESULTS: The frequency of stricture was not significantly different between the groups because of insufficient statistical power, but the number of dilatation sessions required was significantly less in the steroid group (6.1 sessions [95% confidence interval, CI 2.8–9.4] versus 12.5 [95% CI 7.1–17.9] sessions in the control group; P = 0.04). The perforation rate was similar in both groups. The minimum diameter of stenotic lumens was significantly greater in the treatment group than controls (11.0 mm versus 7.1 mm, respectively; P = 0.01). The perforation rate was not significantly different between the groups (1.0% versus 0.5% in the treatment and control group, respectively). Steroid injection was effective in cases of mucosal defects encompassing the entire esophageal circumference. CONCLUSIONS: Prophylactic endoscopic steroid injection appears to be a safe means of relieving the severity of esophageal stenoses following extensive ESD.
format Online
Article
Text
id pubmed-4308850
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43088502015-01-29 A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection Takahashi, Hiroaki Arimura, Yoshiaki Okahara, Satoshi Kodaira, Junichi Hokari, Kaku Tsukagoshi, Hiroyuki Shinomura, Yasuhisa Hosokawa, Masao BMC Gastroenterol Research Article BACKGROUND: Esophageal stenosis following endoscopic submucosal dissection (ESD) is a serious adverse event that makes subsequent management more difficult. METHODS: This parallel, randomized, controlled, open-label study was designed to examine whether local steroid injection is an effective prophylactic treatment for esophageal stenoses following extensive ESD. This single center trial was conducted at the Keiyukai Hospital, a tertiary care center for gastrointestinal disease in Japan [University Hospital Medical Network Clinical Trial Registry (UMIN-CTR) on 15 September 2011 (UMIN000006327)]. Thirty-two patients with mucosal defects involving ≥75% of the esophageal circumference were randomized to receive a single dose of triamcinolone acetonide injections (n = 16) or be treated conventionally (n = 16). The primary outcome was the frequency of stricture requiring endoscopic dilatation; the surrogate primary endpoint was the number of dilatation sessions needed. Secondary outcomes included adverse event rates, the minimum diameter of the stenotic area and the duration of the course of dilatation treatments. RESULTS: The frequency of stricture was not significantly different between the groups because of insufficient statistical power, but the number of dilatation sessions required was significantly less in the steroid group (6.1 sessions [95% confidence interval, CI 2.8–9.4] versus 12.5 [95% CI 7.1–17.9] sessions in the control group; P = 0.04). The perforation rate was similar in both groups. The minimum diameter of stenotic lumens was significantly greater in the treatment group than controls (11.0 mm versus 7.1 mm, respectively; P = 0.01). The perforation rate was not significantly different between the groups (1.0% versus 0.5% in the treatment and control group, respectively). Steroid injection was effective in cases of mucosal defects encompassing the entire esophageal circumference. CONCLUSIONS: Prophylactic endoscopic steroid injection appears to be a safe means of relieving the severity of esophageal stenoses following extensive ESD. BioMed Central 2015-01-22 /pmc/articles/PMC4308850/ /pubmed/25609176 http://dx.doi.org/10.1186/s12876-014-0226-6 Text en © Takahashi et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Takahashi, Hiroaki
Arimura, Yoshiaki
Okahara, Satoshi
Kodaira, Junichi
Hokari, Kaku
Tsukagoshi, Hiroyuki
Shinomura, Yasuhisa
Hosokawa, Masao
A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection
title A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection
title_full A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection
title_fullStr A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection
title_full_unstemmed A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection
title_short A randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection
title_sort randomized controlled trial of endoscopic steroid injection for prophylaxis of esophageal stenoses after extensive endoscopic submucosal dissection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308850/
https://www.ncbi.nlm.nih.gov/pubmed/25609176
http://dx.doi.org/10.1186/s12876-014-0226-6
work_keys_str_mv AT takahashihiroaki arandomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection
AT arimurayoshiaki arandomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection
AT okaharasatoshi arandomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection
AT kodairajunichi arandomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection
AT hokarikaku arandomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection
AT tsukagoshihiroyuki arandomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection
AT shinomurayasuhisa arandomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection
AT hosokawamasao arandomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection
AT takahashihiroaki randomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection
AT arimurayoshiaki randomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection
AT okaharasatoshi randomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection
AT kodairajunichi randomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection
AT hokarikaku randomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection
AT tsukagoshihiroyuki randomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection
AT shinomurayasuhisa randomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection
AT hosokawamasao randomizedcontrolledtrialofendoscopicsteroidinjectionforprophylaxisofesophagealstenosesafterextensiveendoscopicsubmucosaldissection